Genetically Modified Cellular Vaccines for Therapy of Human Papilloma Virus Type 16 (HPV 16)-Associated Tumours

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|8|3|180-186

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.3, 2008-05, pp. : 180-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in human papilloma virus vaccines: a patent review

By Cho Hee-Jeong   Oh Yu-Kyoung   Kim Young Bong  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 3, 2011-03 ,pp. : 295-309

Informa Healthcare

Access to resources Recommend Favorite

A recombinant human papilloma virus (HPV) vaccine [MVA E2] shows promise in the treatment of HPV-induced lesions in men

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The development of antiviral therapy and vaccines against respiratory syncytial virus and human parainfluenza virus type 3

By A J.E.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 4, 2001-08 ,pp. : 175-190

Adis International

Access to resources Recommend Favorite

Genetically Modified Viruses Vaccines by Design

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 1, 2001-03 ,pp. : 47-76

Bentham Science Publishers

Access to resources Recommend Favorite

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine: For the Prevention of Genital Warts in Males

By Garnock-Jones Karly P.  

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 591-602

Adis International

Access to resources Recommend Favorite